EP 2709614 A4 20150415 - PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING CANCER
Title (en)
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING CANCER
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG UND VERFAHREN ZUR BEHANDLUNG VON KREBS
Title (fr)
COMPOSITIONS PHARMACEUTIQUES ET MÉTHODES DE TRAITEMENT DU CANCER
Publication
Application
Priority
- US 201161486851 P 20110517
- US 201161538246 P 20110923
- US 2012038292 W 20120517
Abstract (en)
[origin: WO2012158884A1] The present invention provides pharmaceutical compositions and methods for treating cancer comprising administering a therapeutically effective amount of a 17-alpha hydroxylase/C17, 20-lyase inhibitor.
IPC 8 full level
A61K 31/40 (2006.01); A61K 31/00 (2006.01); A61K 31/4164 (2006.01); A61K 31/4188 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01)
CPC (source: EP)
A61K 31/00 (2013.01); A61K 31/4188 (2013.01); A61K 45/06 (2013.01); A61P 13/08 (2017.12); A61P 15/00 (2017.12); A61P 35/00 (2017.12); A61P 35/04 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
- [XI] US 2009124587 A1 20090514 - AUERBACH ALAN H [US], et al
- [XI] US 2010261689 A1 20101014 - YAMAOKA MASUO [JP], et al
- See references of WO 2012158884A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2012158884 A1 20121122; AR 086444 A1 20131211; CA 2836277 A1 20121122; EP 2709614 A1 20140326; EP 2709614 A4 20150415; JP 2014513730 A 20140605; TW 201309291 A 20130301; UY 34078 A 20121130
DOCDB simple family (application)
US 2012038292 W 20120517; AR P120101759 A 20120518; CA 2836277 A 20120517; EP 12785724 A 20120517; JP 2014511521 A 20120517; TW 101117698 A 20120517; UY 34078 A 20120517